Bicnu Lyophilisate For Solution For Injection 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

BiCNU: Lyophilisate for solution for injection (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

CARMUSTINE, BCNU (kar MUS teen) is a chemotherapy drug. It interferes with the growth of rapidly growing cells like cancer cells. This medicine is used to treat brain tumors, multiple myeloma, Hodgkin's disease, and non-Hodgkin's lymphomas.

In-Depth Information
Select a Medication

BiCNU 100mg Powder for Injection

NDC: 000153012
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Multiple Myeloma, Medulloblastoma, Non-Hodgkin's Lymphoma (NHL), Malignant Glioma, Brain Metastases, Hodgkin's Disease, Astrocytoma

Sometimes used for but not FDA approved for the following conditions:
Malignant Melanoma, Mycosis Fungoides, Stem Cell Transplant Preparation, Cutaneous T-cell Lymphoma (CTCL)

Storage Information
Refrigerate (between 36 and 46 degrees F)
BiCNU 100mg Powder for Injection

Reported Side Effects for BiCNU 100mg Powder for Injection

Elevated Hepatic Enzymes Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Chest Pain Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: EARLY
Infection Incidence:
1.0-18.0%*
Severity: MILD
Onset: DELAYED
Low Blood Pressure Incidence:
1.0%*
Severity: MODERATE
Onset: RAPID
Veno-occlusive Disease (VOD) Incidence:
5.0-20.0%*
Severity: SEVERE
Onset: DELAYED
Sinusoidal Obstruction Syndrome (SOS) Incidence:
5.0-20.0%*
Severity: SEVERE
Onset: DELAYED
Bleeding Incidence:
7.0%*
Severity: MODERATE
Onset: EARLY
Vomiting Incidence:
8.0-21.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
8.0-22.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cell Counts Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Irritated Blood Vessels Incidence:
10.0%*
Severity: MODERATE
Onset: RAPID
Low Platelet Count Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
15.0-28.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with BiCNU

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5